Preimplantation Genetic Diagnosis Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


Market Overview:

Preimplantation genetic diagnosis (PGD) is a technique used for genetic testing of embryos created through in vitro fertilization before pregnancy. PGD helps identify genetic defects in embryos and aids in selection of embryo devoid of defects for implantation.

The global Preimplantation Genetic Diagnosis Market is estimated to be valued at US$ 53.5 Mn or Mn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market key trends: 

One of the key trend in the Preimplantation Genetic Diagnosis Market is growing adoption of next generation sequencing. The increasing preference for non-invasive sampling techniques like sequential embryo biopsy has boosted adoption of next generation sequencing techniques like whole genome amplification in PGD. Next generation sequencing allows analysis of multiple chromosomes simultaneously thereby reducing time and cost of the procedure. Rising awareness about advantages of PGD in preventing genetic disorders is also driving the market growth.

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/preimplantation-genetic-diagnosis-market-698

SWOT Analysis

Strength: The preimplantation genetic diagnosis market is driven by increasing genetic abnormalities and growing awareness about genetic disorders. It helps identify genetic defects in embryos before pregnancy and allows selection of healthy embryos. 

Weakness: High procedural costs of preimplantation genetic diagnosis and ethical issues related to conceiving offspring by selection can hinder the market growth. Lack of skilled professionals further limits the market expansion.

Opportunity: Rising healthcare expenditures in developing nations provide new growth avenues. Increasing research activities to develop advanced technologies for improving efficiency and success rates also open up opportunities.

Threats: Strict regulations for genetic testing and social stigma associated with embryo screening pose major threats. Lack of insurance coverage for such procedures in many countries also challenges the market.

Key Takeaways

The global preimplantation genetic diagnosis market is expected to witness high growth, exhibiting a CAGR of 6.2% over the forecast period, due to increasing incidence of genetic disorders and growing awareness about genetic abnormalities. 

Regional analysis 

North America dominates the global market and is expected to continue its dominance during the forecast period, owing to rising healthcare expenditure and presence of key players in the region. Asia Pacific is projected to witness the fastest growth over the next few years due to increasing healthcare infrastructure, rising medical tourism, and growing awareness about genetic disorders in the region.

Key players operating in the preimplantation genetic diagnosis market are Amgen, Quest Diagnostics, Genentech Inc., Vertex, PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., and Laboratory Corporation of America Holdings, Abbott Laboratories, Illumina, Inc., Natera Inc., CooperGenomics Inc., Reproductive Genetics Institute, Inc., Genea Ltd., Invitae Corporation, and CombiMatrix Corporation.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-
Image
The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Market Overview:  Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance.  Market key trends:  One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in ...
Read more